Fate Therapeutics (FATE)
(Delayed Data from NSDQ)
$3.87 USD
-0.13 (-3.25%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $3.91 +0.04 (1.03%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/13/2024
Time: -- |
9/2024 | $-0.42 | 4.33% |
Earnings Summary
For their last quarter, Fate Therapeutics (FATE) reported earnings of -$0.33 per share, beating the Zacks Consensus Estimate of $-0.47 per share. This reflects a positive earnings surprise of 29.79%. Look out for FATE's next earnings release expected on November 13, 2024. For the next earning release, we expect the company to report earnings of -$0.42 per share, reflecting a year-over-year increase of 8.7%.
Earnings History
Price & Consensus
Zacks News for FATE
All You Need to Know About Fate Therapeutics (FATE) Rating Upgrade to Buy
FATE: What are Zacks experts saying now?
Zacks Private Portfolio Services